Indian Naproxen Exporters: Complete Supplier Ranking with Market Share — 366 Manufacturers (2026) — TransData Nexus

Q: Who is the largest naproxen buyer importing from India?

MYLAN PHARMACEUTICALS ULC, (CANADA) is the largest naproxen importer from India with a 15.2% market share and import value of $20.3M.

Q: How many naproxen buyers import from India?

There are 366 active naproxen buyers importing from India, with a combined import market of $133.8M across 3,414 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top naproxen buyers from India?

The top 5 naproxen buyers — MYLAN PHARMACEUTICALS ULC,, GLENMARK PHARMACEUTICALS INC., USA, AMNEAL PHARMACEUTICALS, LLC (KY), KRKA D.D., NOVO MESTO, APL SWIFT SERVICES (MALTA) LTD., — together control 40.2% of total naproxen import value from India.

Suresh Sormare

Naproxen

India Pharmaceutical Trade Intelligence

$133.8M192 Suppliers76 CountriesHS 30049069

ExportsIndia → UNITED STATES42.1%India → CANADA21.1%

ImportsUNITED STATES → India$391.7K GERMANY → India$185.0K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN PHARMACEUTICALS

Market Analysis: Top Importing Countries & Their Importers

1United States

United States emerges as the first largest importing country, achieving a total trade value of $56.4M through 642 shipments. This represents a market share of 42.1% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: United States has a diverse importer base, with their top importers including:

• GLENMARK PHARMACEUTICALS INC., USA - $11.0M (19.5% of country's total business)

• AMNEAL PHARMACEUTICALS, LLC (KY) - $8.7M (15.5% of country's total business)

• DR REDDYS LABORATORIES INC - $4.9M (8.7% of country's total business)

• TIME-CAP LABS, - $3.6M (6.4% of country's total business)

• DR. REDDYS LABORATORIES, INC - $2.7M (4.7% of country's total business)

• Rest of United States's importers - $25.5M (45.3% of country's total business)

Key Insight: United States demonstrates strong market positioning with an average shipment value of $87.8K, indicating premium pricing strategy compared to the market average of $39.2K.

United States is a key market for Naproxen imports, representing 42.1% of total trade value.

Primary Market

Secondary Market

Buyer Segment Analysis

TransData Nexus Naproxen buyer market intelligence

1Buyer Segment Analysis

The 366 buyers of Naproxen imported from India can be categorized into several segments:

1. Pharmaceutical Companies: Entities such as MYLAN PHARMACEUTICALS ULC (Canada), GLENMARK PHARMACEUTICALS INC., USA (United States), and AMNEAL PHARMACEUTICALS, LLC (United States) fall into this category. These companies typically procure large quantities of Naproxen for formulation into finished pharmaceutical products. Their purchasing behavior is characterized by bulk orders and long-term contracts to ensure a steady supply chain.

2. Contract Manufacturers: Companies like KRKA D.D., NOVO MESTO (Slovenia) and DR. REDDY'S LABORATORIES INC (United States) serve as contract manufacturers. They import Naproxen to produce medications on behalf of other pharmaceutical firms. Their order patterns are project-based, aligning with the production schedules and demands of their clients.

3. Distributors and Re-exporters: Entities such as APL SWIFT SERVICES (Malta) LTD. (Malta) and ATNAHS PHARMA UK LIMITED (Spain) act as intermediaries, importing Naproxen for distribution within their domestic markets or for re-export to other regions. Their purchasing behavior is influenced by market demand fluctuations and regulatory considerations in target markets.

4. Retail Chains and Hospital Groups: While not explicitly listed among the top buyers, some entities may represent large retail pharmacy chains or hospital groups that import Naproxen directly to meet the needs of their customers or patients. Their order patterns are typically consistent, reflecting steady demand in the healthcare sector.

The repeat buyer rate of 65.6% indicates a stable and reliable demand for Naproxen, suggesting strong relationships between Indian exporters and these international buyers.

Country-Specific Import Regulations

TransData Nexus Naproxen buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries, the import regulations for Naproxen are as follows:

1. United States:

Regulatory Authority: U.S. Food and Drug Administration (FDA).

Import Registration Process: Importers must ensure that Naproxen is manufactured in facilities registered with the FDA. The product must comply with FDA regulations, including labeling and quality standards.

Estimated Timeline for Registration: The registration process can take several months, depending on the completeness of the application and the FDA's review workload.

Import Tariff/Duty: Pharmaceutical products under HS Code 30049069 are generally duty-free under the Pharmaceutical Agreement of the World Trade Organization (WTO).

2. Canada:

Regulatory Authority: Health Canada.

Demand Drivers & Market Opportunity

TransData Nexus Naproxen buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Naproxen in importing countries is driven by several factors:

1. Disease Prevalence: Naproxen, a non-steroidal anti-inflammatory drug (NSAID), is widely used to treat conditions such as arthritis, musculoskeletal disorders, and acute pain. The prevalence of these conditions contributes significantly to the consistent demand for Naproxen.

2. Government Healthcare Programs: Many countries have government-sponsored healthcare programs that provide essential medicines to their populations. For instance, the inclusion of Naproxen in national essential medicines lists ensures its availability in public healthcare facilities.

3. Universal Health Coverage Expansion: Efforts to expand universal health coverage in various countries have led to increased access to essential medicines, including Naproxen. This expansion supports higher procurement volumes to meet the needs of the population.

4. WHO Essential Medicines List Procurement: Naproxen's inclusion in the World Health Organization's Essential Medicines List underscores its importance in basic healthcare. This inclusion often influences national procurement decisions, leading to sustained demand.

5. Tender-Based Purchasing: Many governments and large healthcare organizations procure medicines through tender processes to ensure cost-effectiveness and supply security. The repeat buyer rate of 65.6% indicates that a significant portion of Naproxen imports is managed through such structured procurement mechanisms.

With 366 buyers across 76 countries, the market for Naproxen imported from India demonstrates robust and diversified demand, presenting substantial opportunities for exporters.

Common Questions — Naproxen Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest naproxen buyer importing from India?

Based on import volume and value, MYLAN PHARMACEUTICALS ULC, (CANADA) leads with $20.3M in imports and a 15.2% market share — the highest of any single naproxen importer. GLENMARK PHARMACEUTICALS INC., USA (UNITED STATES) and AMNEAL PHARMACEUTICALS, LLC (KY) (UNITED STATES) are the next largest buyers.

QHow many companies buy naproxen from India?

There are 366 active naproxen buyers importing from India, with a combined market of $133.8M across 3,414 shipments to 76 countries. The top 5 buyers hold 40.2% of total import value, while the remaining 361 buyers handle the other 59.8%.

QWhich countries import the most naproxen from India?

The top importing countries for naproxen from India are United States (42.1%), Canada (21.1%), Slovenia (16.2%), Malta (6.5%), Spain (4.5%). These markets represent the largest demand centres for Indian pharmaceutical exports of naproxen, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for naproxen from India?

The average import transaction value for naproxen from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Naproxen buyer market intelligence

1Buyer Segment Analysis

The 366 buyers of Naproxen imported from India can be categorized into several segments:

The repeat buyer rate of 65.6% indicates a stable and reliable demand for Naproxen, suggesting strong relationships between Indian exporters and these international buyers.

Country-Specific Import Regulations

TransData Nexus Naproxen buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries, the import regulations for Naproxen are as follows:

1. United States:

Regulatory Authority: U.S. Food and Drug Administration (FDA).

Estimated Timeline for Registration: The registration process can take several months, depending on the completeness of the application and the FDA's review workload.

Import Tariff/Duty: Pharmaceutical products under HS Code 30049069 are generally duty-free under the Pharmaceutical Agreement of the World Trade Organization (WTO).

2. Canada:

Regulatory Authority: Health Canada.

Demand Drivers & Market Opportunity

TransData Nexus Naproxen buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Naproxen in importing countries is driven by several factors:

With 366 buyers across 76 countries, the market for Naproxen imported from India demonstrates robust and diversified demand, presenting substantial opportunities for exporters.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Naproxen

Naproxen

Who Buys Naproxen from India — 366 Importers Behind a $133.8M Market

Top Naproxen Importers — Ranked by Import Value

Top Naproxen Buyers & Importers

Related Analysis

Need Details?

Market Analysis: Top Importing Countries & Importers

Which companies are buying Naproxen — and from which countries?

Naproxen — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1United States

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Naproxen Buyers & Importers

QWho is the largest naproxen buyer importing from India?

QHow many companies buy naproxen from India?

QWhich countries import the most naproxen from India?

QWhat is the average import order value for naproxen from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

2Canada

3Slovenia

4Malta

5Spain

Analysis Methodology